Bml Capital Management, LLC / AVIR
Bml Capital Management, LLC’s Atea Pharmaceuticals Inc Position
Does Bml Capital Management, LLC own Atea Pharmaceuticals Inc (AVIR)? Yes — 7.06M shares worth $38M (+24.38% of its 13F portfolio) as of Q1 2026, down from 7.49M shares the prior filed quarter.
Position Value
$38M
Q1 2026
Shares
7.06M
% of Portfolio
+24.38%
Quarters Held
12
currently held
Position History AVIR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 7.06M | $38M | +24.38% |
| Q4 2025 | 7.49M | $27M | +23.11% |
| Q3 2025 | 7.47M | $22M | +19.85% |
| Q2 2025 | 7.61M | $27M | +20.73% |
| Q1 2025 | 7.61M | $23M | +18.41% |
| Q4 2024 | 7.61M | $25M | +15.83% |
| Q3 2024 | 6.65M | $22M | +13.11% |
| Q2 2024 | 6.38M | $21M | +15.06% |
| Q1 2024 | 5.54M | $22M | +14.75% |
| Q4 2023 | 5.46M | $17M | +12.62% |
| Q3 2023 | 4.80M | $14M | +13.22% |
| Q2 2023 | 2.24M | $8M | +7.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of AVIR.